Clinical trials
Phase 3 Urologic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Completed | 4 |
| Recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Urovant Sciences GmbH | 2 |
| Astellas Pharma Europe Ltd. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bioniche Life Sciences Inc. | 1 |
| Cook MyoSite | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| Johns Hopkins University | 1 |
| University of Missouri-Columbia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urologic Diseases | 14 |
| Kidney Diseases | 5 |
| Glomerulonephritis | 4 |
| Glomerulonephritis, IGA | 4 |
| Renal Insufficiency, Chronic | 4 |
| Urinary Bladder Diseases | 4 |
| Carcinoma, Transitional Cell | 3 |
| Lower Urinary Tract Symptoms | 3 |
| Neoplasms | 3 |
| Neoplasms by Site | 3 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.